Browse EV MemProt Atlas
Supporting publications (n)
Number of publications supporting the inclusion of this protein in EV MemProt Atlas.
EVMP confidence score
Annotation confidence score; open for threshold definitions.
Extremely high >= 0.85High >= 0.70Medium >= 0.55Low >= 0.40| UniProt ID | Protein names | Protein classification | Transmembrane count | Related Diseases | Mediation categories | Download | ||||
|---|---|---|---|---|---|---|---|---|---|---|
| CD9 | P21926 | CD9 antigen (5H9 antigen) (Cell growth-inhibiting gene 2 protein) (Leukocyte antigen MIC3) (Motility-related protein) (MRP-1) (Tetraspanin-29) (Tspan-29) (p24) (CD antigen CD9) | Cancer-related genesCD markersPlasma proteins | 4 | Adhesion and uptake mediationClinical-translation mediationFusion and delivery mediation | 424 | 0.88 | |||
| CD44 | P16070 | CD44 antigen (CDw44) (Epican) (Extracellular matrix receptor III) (ECMR-III) (GP90 lymphocyte homing/adhesion receptor) (HUTCH-I) (Heparan sulfate proteoglycan) (Hermes antigen) (Hyaluronate receptor) (Phagocytic glycoprotein 1) (PGP-1) (Phagocytic glycoprotein I) (PGP-I) (CD antigen CD44) | Blood group antigen proteinsCancer-related genesCD markers | 1 | Ovarian cancerRetinopathySolid tumour/cancer | Adhesion and uptake mediationClinical-translation mediationFusion and delivery mediation | 64 | 0.88 | ||
| PARVB | Q9HBI1 | Beta-parvin (Affixin) | Cancer-related genesPlasma proteinsPredicted intracellular proteins | Adhesion and uptake mediationReceptor-signaling mediation | 55 | 0.88 | ||||
| MYH9 | P35579 | Myosin-9 (Cellular myosin heavy chain, type A) (Myosin heavy chain 9) (Myosin heavy chain, non-muscle IIa) (Non-muscle myosin heavy chain A) (NMMHC-A) (Non-muscle myosin heavy chain IIa) (NMMHC II-a) (NMMHC-IIA) | Cancer-related genesDisease related genesHuman disease related genes | Adhesion and uptake mediationClinical-translation mediationFusion and delivery mediation | 52 | 0.88 | ||||
| RAB25 | P57735 | Ras-related protein Rab-25 (EC 3.6.5.2) (CATX-8) | Cancer-related genesPredicted intracellular proteins | Fusion and delivery mediationMetabolism mediation | 37 | 0.88 | ||||
| P4K2A | Q9BTU6 | Phosphatidylinositol 4-kinase type 2-alpha (EC 2.7.1.67) (Phosphatidylinositol 4-kinase type II-alpha) | EnzymesMetabolic proteinsPredicted intracellular proteins | Fusion and delivery mediationMetabolism mediation | 34 | 0.88 | ||||
| VANG1 | Q8TAA9 | Vang-like protein 1 (Loop-tail protein 2 homolog) (LPP2) (Strabismus 2) (Van Gogh-like protein 1) | Disease related genesHuman disease related genesPotential drug targets | 4 | Receptor-signaling mediation | 26 | 0.88 | |||
| AAAT | Q15758 | Neutral amino acid transporter B(0) (ATB(0)) (Baboon M7 virus receptor) (RD114/simian type D retrovirus receptor) (Sodium-dependent neutral amino acid transporter type 2) (Solute carrier family 1 member 5) | FDA approved drug targetsMetabolic proteinsPlasma proteins | 8 | Clinical-translation mediationFusion and delivery mediationImmune mediation | 25 | 0.88 | |||
| B3A2 | P04920 | Anion exchange protein 2 (AE 2) (Anion exchanger 2) (Non-erythroid band 3-like protein) (BND3L) (Solute carrier family 4 member 2) | Metabolic proteinsPredicted intracellular proteinsPredicted membrane proteins | 10 | Adhesion and uptake mediationFusion and delivery mediationImmune mediation | 23 | 0.88 | |||
| PRIO | P04156 | Major prion protein (PrP) (ASCR) (PrP27-30) (PrP33-35C) (CD antigen CD230) | CD markersDisease related genesHuman disease related genes | Adhesion and uptake mediationClinical-translation mediationFusion and delivery mediation | 21 | 0.88 | ||||
| WDR1 | O75083 | WD repeat-containing protein 1 (Actin-interacting protein 1) (AIP1) (NORI-1) | Disease related genesEssential proteinsHuman disease related genes | Fusion and delivery mediationImmune mediation | 50 | 0.75 | ||||
| GBB1 | P62873 | Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1 (Transducin beta chain 1) | Cancer-related genesDisease related genesHuman disease related genes | Clinical-translation mediationFusion and delivery mediationImmune mediation | 42 | 0.75 | ||||
| AGRIN | O00468 | Agrin [Cleaved into: Agrin N-terminal 110 kDa subunit; Agrin C-terminal 110 kDa subunit; Agrin C-terminal 90 kDa fragment (C90); Agrin C-terminal 22 kDa fragment (C22)] | Disease related genesHuman disease related genesPlasma proteins | Clinical-translation mediationImmune mediationMetabolism mediation | 36 | 0.75 | ||||
| EF2 | P13639 | Elongation factor 2 (EF-2) (EC 3.6.5.-) | Cancer-related genesDisease related genesEssential proteins | Clinical-translation mediationImmune mediationMetabolism mediation | 35 | 0.75 | ||||
| PYGL | P06737 | Glycogen phosphorylase, liver form (EC 2.4.1.1) | Disease related genesEnzymesHuman disease related genes | Immune mediationMetabolism mediation | 34 | 0.75 | ||||
| CYTB | P04080 | Cystatin-B (CPI-B) (Liver thiol proteinase inhibitor) (Stefin-B) | Cancer-related genesDisease related genesHuman disease related genes | Immune mediation | 31 | 0.75 | ||||
| ARPC5 | O15511 | Actin-related protein 2/3 complex subunit 5 (Arp2/3 complex 16 kDa subunit) (p16-ARC) | Plasma proteinsPredicted intracellular proteins | Adhesion and uptake mediationClinical-translation mediationFusion and delivery mediation | 28 | 0.75 | ||||
| KGUA | Q16774 | Guanylate kinase (EC 2.7.4.8) (GMP kinase) (Guanylate kinase 1) | EnzymesEssential proteinsMetabolic proteins | Clinical-translation mediationFusion and delivery mediationMetabolism mediation | 23 | 0.75 | ||||
| MAP4 | P27816 | Microtubule-associated protein 4 (MAP-4) | FDA approved drug targetsPlasma proteinsPredicted intracellular proteins | Clinical-translation mediation | 21 | 0.75 | ||||
| RB6I2 | Q8IUD2 | ELKS/Rab6-interacting/CAST family member 1 (ERC-1) (Rab6-interacting protein 2) | Cancer-related genesDisease related genesPredicted intracellular proteins | Fusion and delivery mediation | 20 | 0.72 | ||||
| S10A9 | P06702 | Protein S100-A9 (Calgranulin-B) (Calprotectin L1H subunit) (Leukocyte L1 complex heavy chain) (Migration inhibitory factor-related protein 14) (MRP-14) (p14) (S100 calcium-binding protein A9) | Cancer-related genesPlasma proteinsPredicted intracellular proteins | Lupus erythematosusProstate cancer | Clinical-translation mediationFusion and delivery mediationImmune mediation | 19 | 0.72 | |||
| CLD4 | O14493 | Claudin-4 (Clostridium perfringens enterotoxin receptor) (CPE-R) (CPE-receptor) (Williams-Beuren syndrome chromosomal region 8 protein) | Cancer-related genesDisease related genesHuman disease related genes | 4 | Adhesion and uptake mediationFusion and delivery mediationReceptor-signaling mediation | 18 | 0.72 | |||
| HMOX1 | P09601 | Heme oxygenase 1 (HO-1) (EC 1.14.14.18) [Cleaved into: Heme oxygenase 1 soluble form] | Cancer-related genesDisease related genesEnzymes | 1 | Neonatal hyperbilirubinaemia | Clinical-translation mediationFusion and delivery mediationImmune mediation | 18 | 0.72 | ||
| KCNN4 | O15554 | Intermediate conductance calcium-activated potassium channel protein 4 (SKCa 4) (SKCa4) (hSK4) (Gardos channel) (IKCa1) (hIK1) (KCa3.1) (Putative Gardos channel) (hKCa4) | Disease related genesFDA approved drug targetsHuman disease related genes | 6 | Alzheimer diseaseChronic painConjunctiva disorder | Clinical-translation mediationFusion and delivery mediationImmune mediation | 17 | 0.72 | ||
| KLK7 | P49862 | Kallikrein-7 (hK7) (EC 3.4.21.117) (Serine protease 6) (Stratum corneum chymotryptic enzyme) (hSCCE) | Cancer-related genesEnzymesPredicted intracellular proteins | Immune mediation | 17 | 0.72 |